ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
62 894,07
-1,33%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Incyte Corporation (INCY)

  7. Incyte Corporation (INCY) Actualités

INCY Incyte Corporation

51,15
-0,03 (-0,06%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Incyte Corporation INCY NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,03 -0,06% 51,15 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
50,99 50,86 51,85 51,68 51,18
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202400:11BWIncyte annonce l'acquisition d'Escient Pharmaceuticals et de..
24/4/202400:01BWIncyte gibt Übernahme von Escient Pharmaceuticals und dessen..
23/4/202413:00BWIncyte Announces Acquisition of Escient Pharmaceuticals and..
11/4/202414:00BWIncyte to Report First Quarter Financial Results
01/4/202414:30BWIncyte and CMS Announce Collaboration and License Agreement..
29/3/202421:30BWIncyte Reports Inducement Grant Under Nasdaq Listing Rule..
11/3/202413:57BWIncyte gibt neue Daten aus Phase-2-Studie zur Untersuchung..
11/3/202411:06BWIncyte présente de nouvelles données de l’étude de phase 2..
11/3/202410:53BWIncyte legt neue brandaktuelle Daten aus Phase-2-Studie zur..
10/3/202421:05BWIncyte Presents New Late-Breaking Data from Phase 2 Study..
04/3/202420:38BWDe nouvelles données dérivées du portefeuille dermatologique..
04/3/202420:02BWNeue Daten aus dem wachsenden Dermatologieportfolio von..
04/3/202414:00BWNew Data from Incyte’s Growing Dermatology Portfolio to be..
29/2/202416:19BWIncyte Launches The Unseen Journey to Elevate the Hidden..
29/2/202413:30GLOBEKnight Therapeutics Announces Launch of Minjuvi® in Brazil
28/2/202415:11BWIncyte annonce que la Food and Drug Administration des..
28/2/202413:15BWIncyte gibt bekannt, dass die US-Arzneimittelbehörde FDA..
27/2/202422:08BWIncyte Announces U.S. Food and Drug Administration Grants..
16/2/202422:04EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
16/2/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202414:00BWIncyte to Present at Upcoming Investor Conference
14/2/202418:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/2/202422:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
13/2/202413:03EDGAR2Form 8-K - Current report
13/2/202413:00BWIncyte Reports 2023 Fourth Quarter and Year-End Financial..
06/2/202410:08BWIncyte erhält exklusive weltweite Rechte für die Entwicklung..
06/2/202402:55BWIncyte obtient les droits exclusifs de développement et de..
05/2/202422:46BWIncyte Gains Exclusive Global Development and..
24/1/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202420:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202414:00BWIncyte to Report Fourth Quarter and Year-End 2023 Financial..
22/1/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202419:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202419:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202419:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202419:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202420:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
INCY
Incyte
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés